Calidi Biotherapeutics, Inc. (CLDI) Misses Q2 EPS by 121c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St climbs as oil slips; SpaceX spectrum deal weighs on telecoms
- Oil falls as Trump comments on Iran talks ease supply concerns
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| (NYSE: CLDI) | Delayed: 1.03 -0.01 (0.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.04 | 52 Week High | $ | |||
| Open | $1.04 | 52 Week Low | $ | |||
| Day High | $1.04 | P/E | N/A | |||
| Day Low | $1.03 | EPS | $ | |||
| Volume | 7,273 | |||||
